These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9826169)

  • 1. Diagnostic value of CD34 immunostaining in desmoplastic trichilemmoma.
    Illueca C; Monteagudo C; Revert A; Llombart-Bosch A
    J Cutan Pathol; 1998 Sep; 25(8):435-9. PubMed ID: 9826169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An immunohistochemical study of lysozyme, CD-15 (Leu M1), and gross cystic disease fluid protein-15 in various skin tumors. Assessment of the specificity and sensitivity of markers of apocrine differentiation.
    Ansai S; Koseki S; Hozumi Y; Kondo S
    Am J Dermatopathol; 1995 Jun; 17(3):249-55. PubMed ID: 8599433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the hair stem cell-specific marker nestin in epidermal and follicular tumors.
    Kanoh M; Amoh Y; Sato Y; Katsuoka K
    Eur J Dermatol; 2008; 18(5):518-23. PubMed ID: 18693153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desmoplastic trichilemmoma: a rare tumor of the eyelid.
    Keskinbora KH; Buyukbabani N; Terzi N
    Eur J Ophthalmol; 2004; 14(6):562-4. PubMed ID: 15638108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desmoplastic trichilemmoma: a case report with immunohistochemical characterization of the extracellular matrix components.
    Massi D; Franchi A
    Acta Derm Venereol; 1997 Sep; 77(5):347-9. PubMed ID: 9298125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistologic differential diagnosis of basal cell carcinoma, squamous cell carcinoma, and trichoepithelioma in small cutaneous biopsy specimens.
    Swanson PE; Fitzpatrick MM; Ritter JH; Glusac EJ; Wick MR
    J Cutan Pathol; 1998 Mar; 25(3):153-9. PubMed ID: 9550314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desmoplastic trichilemmoma.
    Tellechea O; Reis JP; Baptista AP
    Am J Dermatopathol; 1992 Apr; 14(2):107-4. PubMed ID: 1373583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of CD34 in assessing the relationship between stroma and tumor in desmoplastic keratinocytic neoplasms.
    Kirchmann TT; Prieto VG; Smoller BR
    J Cutan Pathol; 1995 Oct; 22(5):422-6. PubMed ID: 8594074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Cytokeratin 17 in the Differentiation Between Desmoplastic Trichilemmoma and Cutaneous Basal Cell Carcinoma.
    Chaudet KM; Stagner AM; Nazarian RM
    Am J Dermatopathol; 2022 Dec; 44(12):886-890. PubMed ID: 36197047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of immunostaining for bcl-2 and CD34 and the lectin peanut agglutinin in differentiating between basal cell carcinomas and trichoepitheliomas.
    Basarab T; Orchard G; Russell-Jones R
    Am J Dermatopathol; 1998 Oct; 20(5):448-52. PubMed ID: 9790103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-beta and bcl-2 distribution patterns distinguish trichoepithelioma from basal cell carcinoma.
    Verhaegh ME; Arends JW; Majoie IM; Hoekzema R; Neumann HA
    Dermatol Surg; 1997 Aug; 23(8):695-700. PubMed ID: 9256917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal cell carcinoma arising in association with desmoplastic trichilemmoma.
    Crowson AN; Magro CM
    Am J Dermatopathol; 1996 Feb; 18(1):43-8. PubMed ID: 8721590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pigmented desmoplastic trichilemmoma.
    Martínez-Ciarpaglini C; Monteagudo C
    J Cutan Pathol; 2016 Jun; 43(6):535-537. PubMed ID: 26956243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trichilemmoma arising in the nasal vestibule: report of three cases with special emphasis on the differential diagnosis.
    Herráiz M; Martín-Fragueiro LM; Tardío JC
    Head Neck Pathol; 2012 Dec; 6(4):492-5. PubMed ID: 22669747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trichoblastoma and basal cell carcinoma are neoplasms with follicular differentiation sharing the same profile of cytokeratin intermediate filaments.
    Schirren CG; Rütten A; Kaudewitz P; Diaz C; McClain S; Burgdorf WH
    Am J Dermatopathol; 1997 Aug; 19(4):341-50. PubMed ID: 9261468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunostaining for CD34 to determine trichoepithelioma.
    Bryant D; Penneys NS
    Arch Dermatol; 1995 May; 131(5):616-7. PubMed ID: 7537953
    [No Abstract]   [Full Text] [Related]  

  • 17. CD10 expression in trichoepithelioma and basal cell carcinoma.
    Pham TT; Selim MA; Burchette JL; Madden J; Turner J; Herman C
    J Cutan Pathol; 2006 Feb; 33(2):123-8. PubMed ID: 16420307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD34 staining pattern distinguishes basal cell carcinoma from trichoepithelioma.
    Kirchmann TT; Prieto VG; Smoller BR
    Arch Dermatol; 1994 May; 130(5):589-92. PubMed ID: 7513986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunolabeling pattern of podoplanin (d2-40) may distinguish basal cell carcinomas from trichoepitheliomas: a clinicopathologic and immunohistochemical study of 49 cases.
    Plaza JA; Ortega PF; Bengana C; Stockman DL; Suster S
    Am J Dermatopathol; 2010 Oct; 32(7):683-7. PubMed ID: 20559122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benign cutaneous adnexal tumors with combined folliculosebaceous, apocrine, and eccrine differentiation. Clinicopathologic and immunohistochemical study of eight cases.
    Wong TY; Suster S; Cheek RF; Mihm MC
    Am J Dermatopathol; 1996 Apr; 18(2):124-36. PubMed ID: 8739986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.